About

About

About

EVIIVE is a Swiss biotech company pioneering the next generation of blood-based diagnostics through high-dimensional analysis of extracellular vesicles (EVs). Our mission is to unlock the immune system’s hidden signals to guide more precise, personalized treatment decisions — starting with immunotherapy in cancer.

Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.

At EVIIVE, we believe every patient deserves a biomarker that works for them.

At EVIIVE, we believe every patient deserves a biomarker that works for them.

At EVIIVE, we believe every patient deserves a biomarker that works for them.

Spun out from research at the University of Zurich, we’ve built a proprietary platform that profiles single EVs with exceptional resolution, revealing real-time immune dynamics that traditional biomarkers miss. Our technology is designed to work from just a small volume of plasma, enabling truly non-invasive diagnostics with clinical-grade performance.

We are a multidisciplinary team of scientists, clinicians, and entrepreneurs, working at the intersection of immunology, data science, and translational medicine. With strong academic roots, a growing IP portfolio, and partnerships across pharma and academia, we are rapidly advancing toward clinical implementation.

Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.
Smiling man wearing glasses and a pink shirt, showing his arm with a bandage after vaccination.

Leadership

Leadership

Leadership

Co-Founder & CEO

Molecular immunologist turned entrepreneur with deep EV diagnostics expertise. A former professional mountain biker, he now leads EVIIVE’s vision from bench to market—translating immune insights into investable, clinically meaningful diagnostics.

Co-Founder & CEO

Molecular immunologist turned entrepreneur with deep EV diagnostics expertise. A former professional mountain biker, he now leads EVIIVE’s vision from bench to market—translating immune insights into investable, clinically meaningful diagnostics.

Co-Founder & CEO

Molecular immunologist turned entrepreneur with deep EV diagnostics expertise. A former professional mountain biker, he now leads EVIIVE’s vision from bench to market—translating immune insights into investable, clinically meaningful diagnostics.

Co-Founder & CSO

Innovative molecular & cellular cancer immunologist, recently serving as Prof Dr at the University of Zurich. As scientific architect of EVIIVE’s cutting-edge diagnostic platform, he discovered key biomarkers & translated deep mechanistic insights into novel immuno-oncology diagnostics.

Co-Founder & CSO

Innovative molecular & cellular cancer immunologist, recently serving as Prof Dr at the University of Zurich. As scientific architect of EVIIVE’s cutting-edge diagnostic platform, he discovered key biomarkers & translated deep mechanistic insights into novel immuno-oncology diagnostics.

Co-Founder & CSO

Innovative molecular & cellular cancer immunologist, recently serving as Prof Dr at the University of Zurich. As scientific architect of EVIIVE’s cutting-edge diagnostic platform, he discovered key biomarkers & translated deep mechanistic insights into novel immuno-oncology diagnostics.

Global leader in melanoma research and immunotherapy. Vice Chair of Dermatology at University Hospital Zurich, advising on clinical strategy, physician network development, and regulatory planning.

Global leader in melanoma research and immunotherapy. Vice Chair of Dermatology at University Hospital Zurich, advising on clinical strategy, physician network development, and regulatory planning.

Global leader in melanoma research and immunotherapy. Vice Chair of Dermatology at University Hospital Zurich, advising on clinical strategy, physician network development, and regulatory planning.

Scientific Advisor

Head of Pathology at University Hospital Zurich. Internationally recognized for cancer biomarker development and histopathological standards. Guides analytical validation, cohort design, and biomarker interpretation.

Scientific Advisor

Head of Pathology at University Hospital Zurich. Internationally recognized for cancer biomarker development and histopathological standards. Guides analytical validation, cohort design, and biomarker interpretation.

Scientific Advisor

Head of Pathology at University Hospital Zurich. Internationally recognized for cancer biomarker development and histopathological standards. Guides analytical validation, cohort design, and biomarker interpretation.

Commercial Advisor

Former SVP at Roche Diagnostics and General Manager at Abbott. Strategic advisor to ARCHIMED Investment Group. Brings 20+ years of global diagnostics leadership in Go-to-Market, partnerships, and exits.

Commercial Advisor

Former SVP at Roche Diagnostics and General Manager at Abbott. Strategic advisor to ARCHIMED Investment Group. Brings 20+ years of global diagnostics leadership in Go-to-Market, partnerships, and exits.

Commercial Advisor

Former SVP at Roche Diagnostics and General Manager at Abbott. Strategic advisor to ARCHIMED Investment Group. Brings 20+ years of global diagnostics leadership in Go-to-Market, partnerships, and exits.

Supported By

Supported By

Supported By

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.

Winterthurerstrasse 190
Irchel Y23K74
Zürich 8057
Switzerland

EVIIVE is a registered entity in Zürich, Switzerland. All scientific content, claims, or technologies referenced on this site are for informational purposes only and are subject to ongoing research, regulatory evaluation, and change. This site does not provide medical advice or substitute professional consultation.